Inactive Instrument

News Clinigen Group plc

Equities

CLIN

GB00B89J2419

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Clinigen Launches NaviGATE an Educational Programme for Rare Disease Patients and Organizations	23-09-12	CI
CNX Therapeutics Limited acquired Cardioxane® (dexrazoxane), Savene® (dexrazoxane), Totect® (dexrazoxane) and Ethyol®, four cancer support therapies from Clinigen Limited.	23-08-09	CI
Clinigen Limited Reports Earnings Results for the Full Year Ended June 30, 2022	23-05-08	CI
Adragos Pharma GmbH completed the acquisition of Lamda Laboratories S.A. from Clinigen Limited.	23-04-02	CI
JCR Pharmaceuticals implements IZCARGO Named Patient Supply Program	23-03-28	AQ
Clinigen : Supplier Code of Conduct 2023	23-03-28	PU
Adragos Pharma acquires Clinigen's development unit, Lamda Laboratories	23-03-20	AQ
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories	23-03-20	AQ
Adragos Pharma GmbH signed a definitive agreement to acquire Lamda Laboratories S.A. from Clinigen Limited.	23-03-19	CI
Clinigen : Global Human Rights & Anti Slavery Policy	23-03-10	PU
Clinigen : Global Anti-Bribery & Corruption Policy	23-03-10	PU
Clinigen : Global Anti-Money Laundering Policy	23-03-10	PU
Clinigen : Global Anti-Trust Policy	23-03-10	PU
Clinigen : Global Health & Safety Policy	23-03-10	PU
Clinigen : Global Freedom to Speak Up Policy	23-03-10	PU
Clinigen : Global Data Protection Policy	23-03-10	PU
Clinigen : Global Diversity, Equity & Inclusion Policy	23-03-10	PU
Clinigen : Global Environmental Policy	23-03-10	PU
Clinigen : Global Human Rights & Anti Slavery Policy	23-02-03	PU
Iovance Biotherapeutics, Inc. entered into a definitive agreement to acquire Worldwide rights of Proleukin of Clinigen Limited for approximately £210 million.	23-01-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Clinigen Group plc

Equities

CLIN

GB00B89J2419

Summary

Filters